Enterococcal vaccine conjugate - Nabi

Drug Profile

Enterococcal vaccine conjugate - Nabi

Alternative Names: Enterococcus faecalis conjugate vaccine; EnteroVAX; Nabi-EnteroVAX

Latest Information Update: 11 Jun 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nabi Biopharmaceuticals
  • Class Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Enterococcal infections

Most Recent Events

  • 11 Jun 2008 Discontinued - Preclinical for Enterococcal infections in USA (Parenteral)
  • 20 Feb 2008 Preclinical development is ongoing
  • 23 May 2006 This vaccine is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top